Literature DB >> 11687798

Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure.

R Birkenhäger1, E Otto, M J Schürmann, M Vollmer, E M Ruf, I Maier-Lutz, F Beekmann, A Fekete, H Omran, D Feldmann, D V Milford, N Jeck, M Konrad, D Landau, N V Knoers, C Antignac, R Sudbrak, A Kispert, F Hildebrandt.   

Abstract

Antenatal Bartter syndrome (aBS) comprises a heterogeneous group of autosomal recessive salt-losing nephropathies. Identification of three genes that code for renal transporters and channels as responsible for aBS has resulted in new insights into renal salt handling, diuretic action and blood-pressure regulation. A gene locus of a fourth variant of aBS called BSND, which in contrast to the other forms is associated with sensorineural deafness (SND) and renal failure, has been mapped to chromosome 1p. We report here the identification by positional cloning, in a region not covered by the human genome sequencing projects, of a new gene, BSND, as the cause of BSND. We examined ten families with BSND and detected seven different mutations in BSND that probably result in loss of function. In accordance with the phenotype, BSND is expressed in the thin limb and the thick ascending limb of the loop of Henle in the kidney and in the dark cells of the inner ear. The gene encodes a hitherto unknown protein with two putative transmembrane alpha-helices and thus might function as a regulator for ion-transport proteins involved in aBS, or else as a new transporter or channel itself.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687798     DOI: 10.1038/ng752

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  156 in total

Review 1.  Application of physiological genomics to the study of hearing disorders.

Authors:  Stefan Heller
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

Review 2.  Use of knock-out mouse models for the study of renal ion channels.

Authors:  H Barrière; M Tauc; P Poujeol
Journal:  J Membr Biol       Date:  2004-04-01       Impact factor: 1.843

Review 3.  CLC-K channels: if the drug fits, use it.

Authors:  Peying Fong
Journal:  EMBO Rep       Date:  2004-06       Impact factor: 8.807

4.  Identification of sites responsible for the potentiating effect of niflumic acid on ClC-Ka kidney chloride channels.

Authors:  G Zifarelli; A Liantonio; A Gradogna; A Picollo; G Gramegna; M De Bellis; A R Murgia; E Babini; D Conte Camerino; M Pusch
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

5.  Twenty-five years of CLC chloride transport proteins.

Authors:  Peying Fong
Journal:  J Physiol       Date:  2015-09-15       Impact factor: 5.182

Review 6.  Improving Molecular Therapy in the Kidney.

Authors:  Jeffrey D Rubin; Michael A Barry
Journal:  Mol Diagn Ther       Date:  2020-08       Impact factor: 4.074

7.  Type IV Bartter syndrome: report of two new cases.

Authors:  Marco Zaffanello; Anna Taranta; Alessia Palma; Alberto Bettinelli; Gian Luigi Marseglia; Francesco Emma
Journal:  Pediatr Nephrol       Date:  2006-04-01       Impact factor: 3.714

Review 8.  Emerging Targets of Diuretic Therapy.

Authors:  C-J Cheng; A R Rodan; C-L Huang
Journal:  Clin Pharmacol Ther       Date:  2017-07-10       Impact factor: 6.875

Review 9.  Salt handling and hypertension.

Authors:  Kevin M O'Shaughnessy; Fiona E Karet
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 10.  Physiological roles of CLC Cl(-)/H (+) exchangers in renal proximal tubules.

Authors:  Vanessa Plans; Gesa Rickheit; Thomas J Jentsch
Journal:  Pflugers Arch       Date:  2008-10-14       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.